Aggrastat

CARDIOME PHARMA CORP (NASDAQ: CRME) announced Tuesday it has agreed to divest its Canadian business to Cipher Pharmaceuticals for the U.S. dollar equivalent of $19.7 million.  The Analyst Canaccord Genuity's Dewey Steadman maintains a Buy rating on Cardiome's stock with an unchanged...